Stroup Research Program

Research Overview

The New Jersey State Cancer Registry

The New Jersey State Cancer Registry (NJSCR) collects and maintains population-based cancer surveillance data for the over 50,000 cases diagnosed and/or treated each year in the State of New Jersey. With a repository of more than 1.8 million cases diagnosed from 1979-2017, the NJSCR data will be used for local, state, national and international cancer surveillance programs including the CDC National Program of Cancer Registries (NPCR), the NCI Surveillance, Epidemiology, and End-Results (SEER) Program, the North American Association of Central Cancer Registries (NAACCR), the International Agency for Research on Cancer (IARC), and global surveillance on cancer survival through the CONCORD program.

Researchers may request NJSCR data through the Cancer Surveillance Research Program (CSRP). These data are provided for the purpose of determining the incidence and etiology of malignant neoplasms and/or evaluating measures designed to eliminate, alleviate, or reduce the impact of cancer. The CSRP collaborates with many researchers to facilitate cancer research using the NJSCR. CSRP services include data requests, registry analytics, data linkages, survey administration, medical record abstraction, and biospecimen collection. In addition to patient demographic and cancer information, the NJSCR provides geocoded data, treatment, and survival data for research.

If you are a researcher interested in conducting an epidemiologic study using NJSCR data, please visit the CSRP website here. Visit Special Studies and Publications for examples of how researchers have used NJSCR data.

Cancer Surveillance Research and Cancer Health Disparities

Cancer disparities are often identified from population-based surveillance data that are routinely captured by statewide cancer registries like the NJSCR. Dr. Stroup’s expertise in cancer surveillance research and descriptive epidemiology has led to research that not only advances methods to assess the burden of disease in large geographically-defined populations, but has led to a growing disparities research portfolio to identify special populations that might be at greater risk for cancer or are underserved. This field of study requires expertise in epidemiological methods and cancer surveillance, but also requires a multidisciplinary team of investigators with specific subject matter expertise covering the cancer care continuum from screening among unaffected populations to long-term cancer outcomes and survivorship. Combining her expertise with subject matter experts has resulted in important contributions in the areas of surveillance methodologies, cancer screening, and population-based outcomes and disparities research.